Bone metastasis predicts poor prognosis of patients with brain metastases from colorectal carcinoma post aggressive treatment

  title={Bone metastasis predicts poor prognosis of patients with brain metastases from colorectal carcinoma post aggressive treatment},
  author={H. Duan and Zhenqiang He and Cheng-cheng Guo and Juehui Li and J. Wang and Zhe Zhu and K. Sai and Z. Chen and Xiao-Bing Jiang and Yong-gao Mou},
  journal={Cancer Management and Research},
  pages={2467 - 2474}
Purpose The presence of brain metastasis (BM) in patients with colorectal cancer (CRC) is usually associated with terminal-stage illness; however, a subgroup of patients receiving aggressive treatment can have a satisfactory prognosis. This study was designed to investigate the profile of prognostic factors in CRC patients with BM treated aggressively. Patients and methods CRC patients with BM were retrospectively reviewed. Survival analysis was performed to identify potential prognostic… Expand
Brain Metastases from Colorectal Cancer: A Systematic Review of the Literature and Meta-Analysis to Establish a Guideline for Daily Treatment
Several factors including age, blood levels of carcinoembryonic antigen (CEA), multiple metastases sites, number of brain lesions, and presence of the KRAS mutation were predictors of OS. Expand
AU-rich element-binding proteins in colorectal cancer
Targeting these AUBPs to restore efficient post-transcriptional regulation of gene expression may represent an appealing therapeutic strategy for colorectal cancer. Expand


Brain Metastasis from Colorectal Cancer: Predictors and Treatment Outcomes
CRC patients with metastasis to the lung or bone were at a higher risk of BM, and stereotactic radiosurgery, administered to 41% of the patients with BM, was associated with a better postdiagnostic survival. Expand
Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experience.
The ability to deliver combined-modality local brain therapy as well as availability of more systemic therapy options appear to lead to improved outcomes, and the administration of biologic agents was safe and well tolerated. Expand
Prognostic factors and multidisciplinary treatment modalities for brain metastases from colorectal cancer: analysis of 93 patients
Surgical resection of BMs from CRC in selected patients may help prolong survival and additional radiotherapy following surgery is valuable in improving prognosis. Expand
Brain metastases from colorectal carcinoma: a description of 60 cases in a single Chinese cancer center
Although BM from CRC is a late-stage phenomenon with an extremely poor prognosis, some subsets of patients would benefit from a multidisciplinary management strategy and a low RPA class and a limited number of brain lesions may predict increased survival after therapy for CRC patients with BM. Expand
Prognostic Factors and Treatment Effects in Patients With Curatively Resected Brain Metastasis From Colorectal Cancer
Neurosurgical resection in select patients is a reasonable option for brain metastasis from colorectal cancer, although it is not associated with long-term (5-year) survival. Expand
Prognostic factors for patients with advanced colorectal cancer and symptomatic brain metastases.
The results suggest that advancements in continuing systemic chemotherapy prolong survival among patients with BMs from CRC, and Clinicians should be especially aware of BMs in patients with lung metastases. Expand
Brain metastases from colorectal carcinoma: prognostic factors and outcome
Overall prognosis of patients with brain metastases from CRC is poor, Nevertheless, patients with low RPA class, or those with previous less chemotherapy showed good prognosis, indicating that proper treatment may result in improved survival time. Expand
Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
The results show that most mCRC pts develop BM as a late step in the course of disease, and when BM is present survival is poor. Expand
Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution.
Brain metastases from crc develop late in the course of the disease, given that most patients already have other secondary lesions, and prognosis in these patients is poor, with those receiving treatment with surgery and wbrt having the best overall survival. Expand
Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center
The local approach demonstrated to be superior in terms of survival compared to the regional/systemic approach (whole brain radiotherapy and chemotherapy) and proper selection of patients who are candidate to local treatments is of crucial importance. Expand